← Leaderboards
Lynne L. Johnson
Rhode Island Hospital (Providence, Ri)
$5,964,583
Attributed
$7,939,342
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–19$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,939,342 · 6
By mechanism
R01$7,939,342 · 6
Top collaborators
- Jeanine M D'Armiento6 shared
- Gebhard Wagener3 shared
Most similar at Rhode Island Hospital (Providence, Ri)
Same institution · by research overlap
- Conrad E Johanson$2,171,042
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelUptakeMonitorImageTomography, Emission-Computed, Single-PhotonReceptorAdvanced Glycosylation End ProductsAntibodiesIn VivoApoptosisSignal TransductionMeasurementMolecular ImagingPathway InteractionsResearch StudyFamily SuidaeAnimalsDoseGlucoseLigandsDiabetes MellitusDiabeticNon-DiabeticBinding (Molecular Function)
Grant awards (18)
Novel Therapy for Diabetic PAD Monitored With Dual Isotope Multimodality Imaging$466,246
R01 · FY2019 · HL · contact PI
In vivo imaging of destructive processes in COPD$696,374
R01 · FY2018 · HL
Novel Therapy for Diabetic PAD Monitored With Dual Isotope Multimodality Imaging$480,570
R01 · FY2018 · HL · contact PI
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2017 · HL
Novel Therapy for Diabetic PAD Monitored With Dual Isotope Multimodality Imaging$480,570
R01 · FY2017 · HL · contact PI
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2016 · HL
Novel Therapy for Diabetic PAD Monitored With Dual Isotope Multimodality Imaging$468,107
R01 · FY2016 · HL · contact PI
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$392,000
R01 · FY2014 · HL
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$373,946
R01 · FY2013 · HL
RAGE-directed imaging in diabetes-induced accelerated atherosclerosis$398,475
R01 · FY2012 · HL · contact PI
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$381,010
R01 · FY2012 · HL
RAGE-directed imaging in diabetes-induced accelerated atherosclerosis$402,500
R01 · FY2011 · HL · contact PI
RAGE-directed imaging in diabetes-induced accelerated atherosclerosis$402,500
R01 · FY2010 · HL · contact PI
RAGE-directed imaging in diabetes-induced accelerated atherosclerosis$402,500
R01 · FY2009 · HL · contact PI
Imaging and Laser Revascularization in Hibernation$306,559
R01 · FY2003 · HL
Imaging and Laser Revascularization in Hibernation$306,559
R01 · FY2002 · HL
Imaging and Laser Revascularization in Hibernation$333,747
R01 · FY2001 · HL
IMAGING INTIMAL HYPERPLASIA, MYOCYTE HYPOXIA, NECROSIS$242,131
R01 · FY2000 · HL